Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 4.280
-0.240 (-5.31%)
Jul 30, 2026, 4:08 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 8.16 billion as of July 29, 2026. Its market cap has decreased by -40.13% in one year.
Market Cap
8.16B
Enterprise Value
8.25B
Revenue
1.04B
Ranking
n/a
PE Ratio
27.28
Stock Price
4.28
ChartMarket Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 8.16B, a decrease of -31.13%. That is a compound annual growth rate of -8.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 8.16B | -9.05% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 9.49B |
| Shaanxi Micot Pharmaceutical Technology | 9.34B |
| TenNor Therapeutics (Suzhou) | 8.78B |
| Everest Medicines | 8.72B |
| Suzhou Ribo Life Science | 8.51B |
| CARsgen Therapeutics Holdings | 7.84B |
| Alphamab Oncology | 7.75B |
| Abbisko Cayman | 7.42B |